Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : The Epic American Credit and Bond Bubble Laboratory -- Ignore unavailable to you. Want to Upgrade?

To: Henry Niman who wrote (33933)	6/5/2005 2:19:11 PM
From: 10K a day	Read Replies (1) \| Respond to of 110194

dude why don't u just get a bird and a room or something.

To: Henry Niman who wrote (33933)	6/6/2005 8:56:04 PM
From: Condor	Respond to of 110194

Scientists Develop Ebola, Marburg Vaccines June 6, 2005 7:11PM Canadian researchers Heinz Feldmann and Steven Jones, along with Thomas Geisbert of USAMRIID report the vaccines have proven 100 percent effective in protecting monkeys against infection from these often deadly viruses. In a major breakthrough, U.S. and Canadian scientists report developing vaccines against Ebola and Marburg effective among primates. The vaccines were developed by the Public Health Agency of Canada in Winnipeg, Manitoba, and the U.S. Army Medical Research Institute of Infectious Diseases in Frederick, Md. A study on their discoveries appears in this month's Nature Medicine. Canadian researchers Heinz Feldmann and Steven Jones, along with Thomas Geisbert of USAMRIID report the vaccines have proven 100 percent effective in protecting monkeys against infection from these often deadly viruses. Monkeys are known to develop hemorrhagic fever symptoms that are similar to those observed in humans infected by these viruses. The safety of vaccines in monkeys is a promising indicator of their real potential for use in humans, the researchers said. sci-tech-today.com